A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors
Clinical trial NCT05351502 · UNKNOWN
Trial details
- NCT number
- NCT05351502
- Sponsor
- Beyond Air Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-14
- Primary completion
- 2025-05-30
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.